Impact of early versus conventional kidney replacement therapy initiation in tumor lysis syndrome: a target trial emulation
Our results do not support the strategy of KRT initiation based on a sole critical phosphatemia level in TLS patients.
Authors
- Marie Lemerle
- Moustafa Abdel-Nabey
- Lara Zafrani
- Lucie Biard (ORCID: https://orcid.org/0000-0003-0660-1264)
- Justine Serre (ORCID: https://orcid.org/0000-0002-1824-931X)
- Charlotte Boud’hors
- Anis Chaba (ORCID: https://orcid.org/0000-0003-2694-7051)
- Guillaume Mulier (ORCID: https://orcid.org/0000-0003-4036-7723)
- Julien Demiselle (ORCID: https://orcid.org/0000-0002-7255-1114)
- Corentin Orvain (ORCID: https://orcid.org/0000-0002-8717-0824)
Institutions
- Délégation Paris 5 (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université Paris Cité (FR)
- Regenerative NanoMedicine (FR)
- Sorbonne Paris Cité (FR)
- Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine (FR)
- Centre Hospitalier Universitaire d'Angers (FR)
- Hôpital Saint-Louis (FR)
- Hôpital Civil, Strasbourg (FR)
- Université d'Angers (FR)
Publication Details
- Journal
- Annals of Intensive Care
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1186/s13613-025-01439-x
- Citations
- 1
- Primary Topic
- Methemoglobinemia and Tumor Lysis Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.52